Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06850545 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Kuopio Lutetium-177 Study in Patients with PSMA-Positive Metastatic Prostate Cancer

Study acronym: KuPSMALu
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
KuPSMALu-trial is an observational study for patients treated with 177LuPSMA-I\&T in Kuopio University Hospital, Finland. Study focuses on efficacy, safety and biomarker research.
Trial Details
NCT Number NCT06850545
Lead Sponsor Kuopio University Hospital
Collaborators: University of Eastern Finland
Conditions
(from sponsor)		 Metastatic Prostate Adenocarcinoma, PSMA PET-Positive Castration-Resistant Prostate Cancer
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov